Deciding if a stem cell transplant is indicated and if a patient is a good candidate for the procedure can be challenging. We welcome your questions about indications for transplantation and patient eligibility.
To ensure the best care for your patients, we:
- Offer experience and expertise on challenging and unique cases
- Provide you with timely and direct communication
- Partner with you for a collaborative approach to your patient’s treatment
- Provide innovative clinical research and compassionate clinical care to your patients
- Return your patient to you and your practice
Recognized for Excellence and Outstanding Outcomes
New data show the David and Etta Jonas Center for Cellular Therapy has the highest one-year survival rate in Illinois for adults undergoing blood and bone marrow stem cell transplants.
UChicago Medicine had an 80% one-year survival rate among adult stem cell patients, according to the latest statistics released in December 2022 by the Center for International Blood & Marrow Transplant Research (CIBMTR) on behalf of the U.S. Health Resources & Services Administration (HRSA). The national average was 76.5%. Learn more about our stem cell transplant outcomes.
The stem cell transplant program at UChicago Medicine is a Blue Cross Center for Distinction and has been named a Center of Excellence by OPTUM, Aetna, Interlink and Cigna. We are fully accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) and the Center for International Blood and Bone Marrow Transplant Research.
Contact Us
Call us at 773-702-1994 or email BMT.Intake@uchospitals.edu for a direct link to the University of Chicago Medicine cancer and stem cell transplant experts and assistance with referrals, admitting patients and consultations.
